Director, Investor Relations
Vericel Corporation
Summary
Vericel Corporation is a pioneer in advanced cell therapies for sports medicine and severe burn care, developing treatments including MACI, Epicel and Nexobrid.
Job description
Position Summary
The Director, Investor Relations will play a key role in executing Vericel's investor relations program and managing the Company's day-to-day engagement with the investment community. Reporting to the Vice President of Finance and Investor Relations, this individual will develop investor communications, manage key investor relations activities, and build relationships with institutional investors and sell-side research analysts.
This position is based at Vericel's Burlington, Massachusetts location and is an onsite position Monday – Thursday, with the option to work remotely on Fridays. Travel for investor conferences, roadshows and other meetings will be required.
Core Responsibilities
Investor Relations Strategy and Messaging
- Partner with the Vice President of Finance and Investor Relations to execute Vericel's investor relations strategy, annual engagement plan and key investor messaging.
- Develop a deep understanding of Vericel's business, products, markets, commercial performance, clinical programs, competitive landscape and long-term strategic objectives.
- Support the development and ongoing refinement of Vericel's investment narrative.
- Identify areas where additional investor education or communication may improve understanding of Vericel's business.
- Help ensure consistency of messaging across earnings materials, investor presentations, SEC filings, press releases, investor meetings and other external communications.
Quarterly Earnings and Financial Communications
- Manage key aspects of the quarterly earnings process in partnership with the Vice President of Finance and Investor Relations, CFO and CEO.
- Develop drafts of earnings call scripts, earnings presentations, management Q&A materials, investor talking points and other supporting materials.
- Coordinate with Finance and FP&A to understand financial performance, forecasts, key business drivers and trends.
- Partner with Legal, Finance and other stakeholders to help ensure investor communications are accurate, consistent and compliant with SEC requirements, Regulation FD and Company disclosure policies.
- Support preparation of investor-related materials and market updates for executive leadership and the Board of Directors.
Investor and Analyst Engagement
- Serve as a day-to-day contact for institutional investors, sell-side research analysts and other members of the investment community.
- Develop and maintain relationships with existing shareholders, prospective investors and research analysts.
- Participate in investor meetings and communicate the Company's strategy, financial performance and investment proposition.
- Prepare the CEO, CFO and other executives for investor conferences, non-deal roadshows, one-on-one investor meetings and other external engagements.
- Participate in investor conferences, roadshows, headquarters meetings, investor calls and other investor engagement activities.
- Support investor targeting efforts designed to identify and build relationships with high-quality prospective long-term shareholders.
- Coordinate with external investor relations advisors, investment banks and other service providers.
Market Intelligence and Investor Insights
- Monitor Vericel's shareholder base, trading activity, institutional ownership and investor engagement trends.
- Gather and synthesize investor and analyst feedback and provide insights to management.
- Maintain a detailed understanding of sell-side research, consensus estimates, valuation methodologies and financial models.
- Monitor the financial performance, valuation, investor messaging and strategic developments of relevant peers.
- Assess broader capital markets and healthcare sector trends and summarize their potential implications for Vericel.
- Develop analyses to help management understand changes in Vericel's valuation, shareholder composition and relative stock performance.
- Identify emerging investor themes and recommend potential areas for additional investor communication.
Investor Communications and Events
- Support development and ongoing maintenance of Vericel's corporate investor presentation and other investor-facing materials.
- Support planning and execution of investor days, analyst events, facility visits and other strategic investor communications initiatives.
- Collaborate with internal teams on investor communications related to significant clinical, regulatory, commercial or corporate developments.
- Support maintenance and continued enhancement of Vericel's investor relations website and associated investor resources.
- Identify opportunities to improve the effectiveness of Vericel's investor communications and engagement program.
Qualifications
- Bachelor's degree, preferably in Finance, Accounting, Economics, Business, Life Sciences or a related discipline.
- MBA, CFA or other advanced degree preferred.
- 8+ years of relevant professional experience in investor relations, equity research, investment banking, investment management, corporate finance or a related capital markets role.
- Experience engaging with institutional investors, research analysts, corporate management teams or investor relations professionals.
- Experience working with publicly traded companies and a strong understanding of the expectations of institutional investors and sell-side analysts.
- Healthcare, medical technology, biotechnology or life sciences experience strongly preferred.
- Demonstrated experience developing investor communications such as earnings materials, corporate presentations, research reports, investment recommendations or transaction materials.
- Strong understanding of financial statements, financial modeling, valuation methodologies and capital markets.
- Experience analyzing sell-side models, consensus estimates, shareholder data and peer-company performance.
- Working knowledge of SEC disclosure requirements, Regulation FD and public company communications practices.
- Experience working with senior executives and preparing executives for investor and analyst interactions.
Knowledge and Skills
- Excellent written and verbal communication skills.
- Strong financial and analytical capabilities with excellent attention to detail.
- Strong presentation skills and professionalism to represent Vericel with external stakeholders.
- Strategic thinker with a strong willingness and ability to execute at a detailed level.
- Strong understanding of how institutional investors evaluate companies.
- Ability to quickly develop expertise in Vericel's products, markets, clinical data, commercial strategy and competitive environment.
- Ability to synthesize financial, market and competitive information.
- Highly collaborative, with the ability to develop strong relationships across functions.
- Strong organizational and project-management skills.
- High level of integrity, discretion and sound judgment.
- Advanced proficiency with Microsoft PowerPoint and Excel.
- Ability and willingness to travel for investor conferences, non-deal roadshows and other investor meetings.
Requirements
- Bachelor's degree, preferably in Finance, Accounting, Economics, Business, Life Sciences or a related discipline
- MBA, CFA or other advanced degree preferred
- 8+ years of relevant professional experience in investor relations, equity research, investment banking, investment management, corporate finance or a related capital markets role
- Experience engaging with institutional investors, research analysts, corporate management teams or investor relations professionals
- Experience working with publicly traded companies and a strong understanding of the expectations of institutional investors and sell-side analysts
- Healthcare, medical technology, biotechnology or life sciences experience strongly preferred
- Demonstrated experience developing investor communications such as earnings materials, corporate presentations, research reports, investment recommendations or transaction materials
- Strong understanding of financial statements, financial modeling, valuation methodologies and capital markets
- Experience analyzing sell-side models, consensus estimates, shareholder data and peer-company performance
- Working knowledge of SEC disclosure requirements, Regulation FD and public company communications practices
- Experience working with senior executives and preparing executives for investor and analyst interactions
- Excellent written and verbal communication skills
- Strong financial and analytical capabilities with excellent attention to detail
- Strong presentation skills
- Strategic thinker with a strong willingness and ability to execute at a detailed level
- Strong understanding of how institutional investors evaluate companies
- Ability to quickly develop expertise in Vericel's products, markets, clinical data, commercial strategy and competitive environment
- Ability to synthesize financial, market and competitive information
- Highly collaborative, with the ability to develop strong relationships across functions
- Strong organizational and project-management skills
- High level of integrity, discretion and sound judgment
- Advanced proficiency with Microsoft PowerPoint and Excel
- Ability and willingness to travel for investor conferences, non-deal roadshows and other investor meetings
Benefits
- Annual Bonus
- Equity Awards
- Comprehensive Benefits Package
Company overview
Vericel Corporation is a leading biotechnology company specializing in advanced cell therapies for sports medicine and severe burn care markets. Founded in 1989 and headquartered in Cambridge, Massachusetts, the company develops and commercializes patient-specific expanded cellular therapies that repair injuries and restore lives. Vericel markets two FDA-approved autologous cell therapy products in the United States: Carticel for cartilage defects in the knee and Epicel for permanent skin replacement in severe burn patients. The company also holds exclusive North American commercial rights to NexoBrid, a biological orphan product for eschar removal in thermal burns. Vericel's innovative approach combines biology with medical technologies to create highly differentiated cell therapies and specialty biologics. With a focus on regenerative medicine, the company is advancing treatments for cartilage repair, burn care, and other severe conditions through rigorous scientific methods and clinical research.